Zota Health Care LImited (ZOTA) - Cash Flow Conversion Efficiency

Latest as of March 2025: -0.220x

Based on the latest financial reports, Zota Health Care LImited (ZOTA) has a cash flow conversion efficiency ratio of -0.220x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-499.64 Million ≈ $-5.40 Million USD) by net assets (Rs2.27 Billion ≈ $24.57 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Zota Health Care LImited liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Zota Health Care LImited - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Zota Health Care LImited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Zota Health Care LImited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zota Health Care LImited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Zuming Bean Products Co Ltd
SHE:003030
0.007x
AB Sagax (publ)
ST:SAGA-A
0.024x
Neurogene Inc
NASDAQ:NGNE
-0.110x
Norske Skog Asa
OL:NSKOG
-0.052x
National Research Corp
NASDAQ:NRC
0.532x
China Railway Prefabricated Construction Co Ltd
SHE:300374
-0.015x
BRBI BR Partners S.A. ADSs
NASDAQ:BRBI
-0.013x
Gorilla Technology Group Inc.
NASDAQ:GRRR
-0.069x

Annual Cash Flow Conversion Efficiency for Zota Health Care LImited (2012–2025)

The table below shows the annual cash flow conversion efficiency of Zota Health Care LImited from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Zota Health Care LImited.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs2.27 Billion
≈ $24.57 Million
Rs-489.47 Million
≈ $-5.29 Million
-0.215x -223.99%
2024-03-31 Rs899.77 Million
≈ $9.73 Million
Rs-59.84 Million
≈ $-647.17K
-0.067x -166.41%
2023-03-31 Rs803.57 Million
≈ $8.69 Million
Rs-20.06 Million
≈ $-216.95K
-0.025x -116.78%
2022-03-31 Rs896.27 Million
≈ $9.69 Million
Rs133.32 Million
≈ $1.44 Million
0.149x +1208.55%
2021-03-31 Rs662.97 Million
≈ $7.17 Million
Rs-8.90 Million
≈ $-96.21K
-0.013x -116.66%
2020-03-31 Rs688.29 Million
≈ $7.44 Million
Rs55.45 Million
≈ $599.62K
0.081x +270.99%
2019-03-31 Rs689.25 Million
≈ $7.45 Million
Rs-32.47 Million
≈ $-351.16K
-0.047x +25.78%
2018-03-31 Rs697.78 Million
≈ $7.55 Million
Rs-44.29 Million
≈ $-479.00K
-0.063x -143.09%
2017-03-31 Rs227.60 Million
≈ $2.46 Million
Rs33.53 Million
≈ $362.62K
0.147x -25.12%
2016-03-31 Rs231.71 Million
≈ $2.51 Million
Rs45.59 Million
≈ $492.99K
0.197x -16.84%
2015-03-31 Rs181.02 Million
≈ $1.96 Million
Rs42.82 Million
≈ $463.11K
0.237x +23.15%
2014-03-31 Rs156.09 Million
≈ $1.69 Million
Rs29.98 Million
≈ $324.27K
0.192x -3.57%
2013-03-31 Rs138.70 Million
≈ $1.50 Million
Rs27.63 Million
≈ $298.80K
0.199x -0.15%
2012-03-31 Rs127.07 Million
≈ $1.37 Million
Rs25.35 Million
≈ $274.14K
0.199x --

About Zota Health Care LImited

NSE:ZOTA India Biotechnology
Market Cap
$418.05 Million
Rs38.66 Billion INR
Market Cap Rank
#13315 Global
#654 in India
Share Price
Rs1274.40
Change (1 day)
+4.36%
52-Week Range
Rs931.75 - Rs1687.00
All Time High
Rs1687.00
About

Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company offers generic drugs, health supplements, over-the-counter products, wellness and ayurvedic products, and nutraceutical products. It provides various medicines for chronic ailments, such as diabetes, cardiac, and thyroid disorders. The company operates its retail stores u… Read more